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Abstract
 
The E2A gene encodes the E47 and E12 basic helix-loop-helix (bHLH) transcription factors. T
cell development in E2A-deficient mice is partially arrested before lineage commitment. Here
we demonstrate that E47 expression becomes uniformly high at the point at which thymocytes
begin to commit towards the T cell lineage. E47 protein levels remain high until the double
positive developmental stage, at which point they drop to relatively moderate levels, and are
further downregulated upon transition to the single positive stage. However, stimuli that
mimic pre-T cell receptor (TCR) signaling in committed T cell precursors inhibit E47 DNA-
binding activity and induce the bHLH inhibitor Id3 through a mitogen-activated protein ki-
nase kinase–dependent pathway. Consistent with these observations, a deficiency in E2A pro-
teins completely abrogates the developmental block observed in mice with defects in TCR
rearrangement. Thus E2A proteins are necessary for both initiating T cell differentiation and
inhibiting development in the absence of pre-TCR expression. Mechanistically, these data link
pre-TCR mediated signaling and E2A downstream target genes into a common pathway.
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Introduction
 
The earliest T cell progenitors in the thymus are found
within a minor population of lymphoid cells defined largely
by the absence of expression of the CD4 and CD8 corecep-
tor molecules (1). The most immature of these double neg-
 
ative (DN)
 
*
 
 thymocytes are characterized by the expression
of the CD44 and CD117 cell surface antigens; these cells
still have multilineage developmental capacity. Commit-
ment to the T cell lineage is largely associated with the in-
duction of CD25 expression, followed by decreases in the
levels of CD44 and CD117. Newly committed T cell pre-
 
cursors then initiate gene rearrangements at the TCR-
 
 
 
, -
 
 
 
,
and -
 
 
 
 loci. The generation of an in-frame TCR 
 
 
 
 gene al-
lows for the expression of the pre-TCR complex, which
contains the TCR 
 
 
 
 chain, the pre-T
 
 
 
 polypeptide, and the
CD3 complex of signal transduction proteins. Signaling
events dependent upon pre-TCR assembly result in a devel-
opmental transition referred to as 
 
 
 
 selection, characterized
by the cessation of gene rearrangement, the initiation of sev-
eral rounds of proliferation, and the differentiation into
 
CD4
 
 
 
 CD8
 
 
 
 double positive (DP) thymocytes. DP cells,
which comprise 75–90% of thymic cellularity, then exit the
cell cycle and initiate TCR-
 
 
 
 gene rearrangements. The ex-
pression of an 
 
  
 
 TCR allows DP cells to undergo affinity-
based positive and negative selection. DP thymocytes that
are positively selected downregulate either CD4 or CD8
and become mature single positive (SP) T cells (2).
E47 and E12 are basic helix-loop-helix (bHLH) tran-
scription factors encoded by the E2A gene that bind DNA
either as homodimers or as heterodimers with other bHLH
proteins (3). E2A-encoded proteins are involved in the dif-
ferentiation of a number of cell types and are particularly
essential for lymphocyte development. In B-lineage cells
the bHLH DNA binding complexes are composed of E47
homodimers whereas in thymocytes mainly heterodimers
of E47 and a related bHLH protein, HEB have been de-
tected. B cell development in E2A- and E47-deficient mice
is completely arrested before Ig gene rearrangement (4–6).
bHLH proteins have also been shown to be important at
multiple stages of T cell development. Thymuses from
E47-deficient mice are markedly hypocellular due to de-
fects preceding T-lineage commitment and the initiation of
TCR gene rearrangements (7). E47 has also been shown to
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be important for the selection process at the DP to SP tran-
sition (8, 9).
 
 
 
In addition, overexpression of E2A protein ac-
tivity has been shown to induce either growth arrest or
apoptosis, indicating that these proteins may regulate cell
proliferation and survival (10–12).
E2A and HEB DNA binding activity is regulated by Id
proteins, which are HLH proteins that lack DNA binding
activity (13). There are four HLH proteins present in ver-
tebrates, Id1–4, of which predominately Id2 and Id3 are
expressed in lymphoid cells (3). Id3 is regulated by the
Erk–mitogen-activated protein kinase (MAPK) pathway in
DP thymocytes (9).
 
 
 
Both positive and negative selection in
Id3 null mutant thymocytes is severely perturbed (14). Ad-
ditionally, Id3-deficient B-lineage cells display defects in
the response to cytokines and mitogenic stimuli (15, 16).
Thus, the E2A proteins and their inhibitor Id3 play essen-
tial roles in lymphocyte maturation.
Here we have examined the role and regulation of E2A
proteins in the development of DN thymocytes. Our ob-
servations indicate that E47 expression is activated in thy-
mocytes at the point during which these cells begin to re-
strict their developmental potential towards the T-lineage.
However, we show that E47 DNA binding activity is
modulated upon signals that mimic 
 
 
 
 selection in DN thy-
mocytes. We also demonstrate that pre-TCR signaling ac-
tivates the expression of Id3, at least in part through an
Erk–MAPK-dependent pathway. Furthermore, we dem-
onstrate that E2A proteins inhibit the DN to DP transition
in the absence of 
 
 
 
 selection. A null mutation in E47 com-
pletely abrogated the developmental block observed in
both recombination activating gene (RAG)-deficient and
 
scid
 
 mutant thymocytes, allowing survival and expansion to
the DP stage and in some cases maturation to the mature
CD8 SP stage as well. Interestingly, E47 heterozygosity
could also lead to aberrant maturation in RAG-null mutant
mice. These data strongly imply that the E2A proteins reg-
ulate genes required for both initiating T cell differentia-
tion and inhibiting development at later stages in the ab-
sence of pre-TCR expression. Furthermore, our data
suggest a model for how signaling from the pre-TCR
complex can regulate E2A target genes.
 
Materials and Methods
 
Mice and Genotyping.
 
Either RAG-1
 
 
 
/
 
 
 
 mice provided by
Randall Johnson (University of California at San Diego) or
RAG-2
 
 
 
/
 
 
 
 mice obtained from Yang Xu (University of Califor-
nia at San Diego) were used for the anti-CD3
 
 
 
 injection experi-
ments. 3–5-wk-old RAG-deficient littermates were injected in-
traperitoneally with 150 
 
 
 
g antibody against CD3
 
 
 
 (2C11 NA/
LE; BD PharMingen). For the bone marrow transfer experiment,
RAG-2
 
 
 
/
 
 
 
 mice were irradiated with 950 rads from a Cesium
source, and then injected intravenously with 7.5 
 
  
 
10
 
6 
 
bone mar-
row cells from an adult E47
 
 
 
/
 
 
 
 RAG-1
 
 
 
/
 
 
 
mouse. Mice het-
erozygous for the E47 and RAG-1 null mutations in a mixed ge-
netic background were obtained from Barbara Kee (University of
California at San Diego) and interbred. 
 
scid
 
 mice in a C57BL/6
background were purchased from the Jackson ImmunoResearch
Laboratories and interbred with mice carrying the E47-null mu-
 
tation (6) in an FVB background. Mice were genotyped for the
E47 and RAG-1 mutations by PCR amplification as described
previously (6, 17). Mice bred into a 
 
scid
 
 background were geno-
typed using a previously described strategy (18).
 
Preparation of Thymocyte Suspensions.
 
Thymuses were dis-
sected from 3–5-wk-old RAG-deficient mice in HBSS. Thy-
mocytes were released by pressing through 70 
 
 
 
m cell strainers
(Falcon) and washed once in HBSS.
 
Flow Cytometric Analyses.
 
Thymocytes (1–10
 
  
 
 10
 
5
 
) were
suspended in 0.1 ml FACS
 
® 
 
buffer (PBS plus 0.1% FCS plus 0.02%
sodium azide) plus the indicated antibodies on ice for 20 min. For
analysis of DN thymocytes for expression of CD25 and CD44,
cells were first incubated with biotinylated antibodies against CD4,
CD8, CD3, CD11b, Gr-1, and TER-119, washed in 1 ml FACS
 
®
 
buffer, and stained anti-CD25-FITC and anti-CD4-PE together
with strepavidin-cychrome or allophycocyanin. Cells were washed
again and fixed in 0.5 ml PBS plus 1% paraformaldehyde. For
analysis of BCL-2 expression cells were first stained with anti-
CD8-PE and anti-CD4-tricolor, washed, and fixed in 1%
paraformaldehyde, permeabilized with 0.1% saponin in PBS, incu-
bated with anti–mouse BCL-2-FITC in PBS plus 0.3% saponin
and 1% BSA for 30 min at 4
 
 
 
C, washed in PBS plus 0.1% saponin,
and resuspended in FACS
 
®
 
 buffer. For analysis of intracellular
TCR-
 
 
 
 or E47 expression cells were first stained for surface anti-
gens, washed in FACS
 
®
 
 buffer, and then fixed, permeabilized, and
stained with anti–TCR-
 
 
 
-FITC or G127-32 (anti-E47) plus goat
anti–mouse-FITC as described previously (19). Analysis was done
using CELLQuest™ software on a FACScan™ or FACScalibur™
(Becton Dickinson). All antibodies were obtained from BD
PharMingen except for anti-CD4-tricolor (Caltag).
 
Electrophoretic Mobility Shift Assay and Immunoblots.
 
Thymo-
cyte suspensions were purified by centrifugation through Ficoll-
Paque (Amersham Pharmacia Biotech) in order to remove dead
cells and stroma. Cells were washed in HBSS, pelleted, and lysed
at 4 
 
 
 
 10
 
7
 
 cells per milliliter in a buffer containing 20 mM
Hepes, pH 7.9, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1
mM DTT, 10 mM NaPO
 
4
 
, 10 mM Na P
 
2
 
O
 
7
 
, 0.1 mM Na vana-
date, protease inhibitors, and 1% NP-40. The insoluble fraction
was then pelleted and removed. electrophoretic mobility shift as-
say (EMSA) was performed using 10–15 
 
 
 
g of whole cell extract
as described in
 
 
 
Bain et al. and references therein. Antibodies used
for antibody interference analysis were G98-271 (mouse IgG1
specific only for human E2A), G127-32 (anti-E47), G127-34
(anti-E12), and G127-382 (anti-HEB, E12 and E2-2). Com-
plexes interfered with by G127-382 preincubation were assumed
to contain HEB, as these complexes did not react with anti-E12
(see Fig. 2 D), and E2-2 has weak EMSA activity (data not
shown). For immunoblot analysis, 30 
 
 
 
g of whole cell extract
was separated on 6% SDS-PAGE via electrophoresis and trans-
ferred to Immobilon (Millipore). The blots were stained with
amido black to confirm that approximately equivalent amounts of
protein were loaded, and then blocked in TBS plus 5% nonfat
dry milk (Blotto). Anti-E47 was used at 1:250 in Blotto. Second-
ary goat anti–mouse conjugated to horseradish peroxidase was
used at 1:10
 
4
 
 and results were visualized with ECL
 
 
 
 (Amersham
Pharmacia Biotech).
 
Northern Blot Analysis.
 
RNA was prepared using TRIzol
(GIBCO BRL) from 10
 
6
 
–10
 
7
 
 thymocytes. DN and DP thy-
mocyte subpopulations were obtained by a combination of com-
plement lysis and cell sorting strategies. 10 
 
 
 
g RNA was sepa-
rated by electrophoresis through a 1% agarose formaldehyde gel.
The RNA was transferred to Nytran (Schleicher and Schuell) and
cross-linked in a Stratalinker (Stratagene). Blots were probed 
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with single stranded PCR-labeled DNA probes. The mouse Id2
probe from nucleotides 230–595 was isolated by reverse tran-
scription PCR. The mouse Id3 probe was a 200-bp DNA frag-
ment isolated by reverse transcription PCR with the following
primers: for: 5
 
 
 
 CGCACTGTTTGCTGCTTTAGG 3
 
 
 
 and rev:
5
 
 
 
 GTAGCAGTGGTTC ATGTCGTC 3
 
 
 
.
 
Thymic Organ Culture.
 
Thymuses were harvested from neona-
tal RAG1
 
 
 
/
 
 
 
 mice and cultured at the media interface on Costar
Transwell inserts (Fisher Scientific), using IMDM (GIBCO BRL)
plus 10% FCS. Penicillin/streptomycin/glutamate (GIBCO BRL),
IL-7, and SCF. Organs were preincubated in the presence or ab-
sence of 30 
 
 
 
M PD98059 (Calbiochem) for 1 h, followed by 2 h of
culture in 10 
 
 
 
g/ml 
 
 
 
-CD3
 
 
 
 before harvest and RNA preparation.
 
Results
 
E47 Expression Is Activated shortly before Commitment to the
T Cell Lineage.
 
Previous studies have suggested roles for
E2A and HEB in the initiation of TCR gene rearrange-
ments and the expression of the Rag and pre-T
 
 
 
 genes
(20–22). These data imply that the expression of bHLH
proteins may be required during the initial stage of T cell
differentiation. Thus, we examined the expression of E47
in DN thymocytes by flow cytometric analysis of perme-
abilized cells stained with an antibody specific for E47. The
expression of E47 was determined in four developmental
stages of DN thymocyte development as defined by the ex-
pression of CD25 and CD44 (23). The majority of
CD44
 
high
 
 CD25
 
 
 
 (DN1) thymocytes, representing cells
that have not committed to T cell development (24), ex-
pressed little or no E47 (Fig. 1 A). However, the expression
of E47 was high within virtually all CD44
 
high
 
 CD25
 
 
 
(DN2) thymocytes, and was also uniformly high in the
CD44
 
low
 
 CD25
 
 
 
 (DN3) and CD44
 
low
 
 CD25
 
 
 
 (DN4) sub-
sets (Fig. 1 A). Transition from the DN1 to the DN2 stage
is closely correlated with a marked biasing of developmen-
tal potential towards the T cell lineage (24). Thus, when
Figure 1. Expression of E47 in thy-
mocyte subsets. The DN thymocytes from
5-wk-old E47 wild-type and  /  mice were
analyzed for E47 expression by flow cytom-
etry. (A) The dot plot depicts flow cytomet-
ric analysis of surface CD25 and CD44 ex-
pression in wild-type DN thymocytes, with
gates drawn for the definition of the sub-
populations analyzed for E47 expression.
The histograms depict the staining of wild-
type (solid line) cells within the DN subsets
for E47, as compared with the staining of
E47 /  DN1 thymocytes (dotted line). The
DN3 and DN4 subset histograms also depict
the staining of the appropriate subsets of
E47 /  thymocytes (thick tracings). As ex-
pected, virtually no events were collected
within the E47 /  DN2 gate. The high-
level staining in a small percentage of wild-
type DN1 cells was also observed when cells
were stained with GAM-FITC but without
anti-E47 (data not shown), therefore these
cells are likely to be mature B cell contami-
nants, which are absent from E47-deficient
mice (reference 6). The very dull “cells” in
the DN4-gated populations most likely rep-
resent contaminating cellular debris, as their mean fluorescence is lower than the background fluorescence of viable cells, and the permeabilization
method required for staining with the anti-E47 antibody decreases the discrimination between live cells and debris by flow cytometry. (B) The dot plot
depicts analysis of CD8 and CD4 expression in wild-type thymocytes, with gates drawn for the definition of DP and SP populations. The histograms de-
pict the staining of wild-type thymocytes (solid line) for E47, as compared with the staining of identically gated populations of E47 /  thymocytes (dot-
ted line). (C) Histogram depicting the staining of wild-type (solid thick tracing), RAG-1 /  (solid thin line) and E47 /  thymocytes (dotted line). These
experiments were repeated two or more times with similar results. 
736
 
E2A Proteins and Early T Cell Development
 
taken together with previous data demonstrating that de-
velopmental progression past the DN1 stage is defective in
E2A-deficient thymocytes (7), these results suggest that the
induction of E2A protein expression in DN thymocytes is
necessary for efficient developmental progression towards
the T-lineage. These data are also consistent with reports
indicating that T cell commitment is blocked by Id3 over-
expression in lymphocyte progenitors (25).
We also examined E47 expression in more mature thy-
mocyte populations by flow cytometry. Immature SP cells,
which represent a transitional stage from DN to DP, ex-
pressed levels similar to that of DN2, DN3, and DN4 thy-
mocytes (reference 26, and data not shown). E47 was
clearly expressed in DP thymocytes, although the majority
of these cells expressed lower levels than that observed in
the DN2, DN3, or DN4 subsets (Fig. 1 B). To confirm our
assessment of the relative levels of E47 in DN and DP cells,
we compared the expression of E47 in wild-type and
RAG-deficient thymocytes. RAG-1 null thymocytes,
which are predominately comprised of DN3 stage cells, ex-
pressed higher E47 levels than did the majority of wild-
type thymocytes, which are largely DP (Fig. 1 C). E47 ex-
pression was downregulated further in mature CD4 and
CD8 SP cells, to levels near the limit that we could detect
by flow cytometry (Fig. 1 B). Thus, E47 protein levels in
thymocytes become high at the point of T cell commit-
ment, are lowered after the DN to the DP transition and
barely detectable in SP cells.
 
E47 DNA Binding Activity Is Modulated upon pre-TCR-
mediated Signaling.
 
E47 DNA binding has been shown to
be modulated by TCR-mediated signaling in DP thy-
mocytes (9). To examine whether bHLH DNA binding
activity is also regulated during the DN to DP transition,
RAG-deficient mice were injected with antibodies against
CD3
 
 
 
 (anti-CD3
 
 
 
). Thymocytes null for either RAG-1 or
RAG-2 exhibit a developmental block at the DN3 stage
due to the inability to rearrange the TCR genes (1). How-
ever, intraperitoneal injection of TCR-
 
 
 
–deficient mice
with anti-CD3
 
 
 
 has been shown to induce developmental
events associated with 
 
 
 
 selection, including progression
from the DN3 to the DN4 and DP stages together with
proliferation and expansion of the thymocyte pool (27,
28). Thymocyte populations derived from RAG-deficient
mice that were injected with anti-CD3 were harvested at
various time points and analyzed by flow cytometry for
developmental progression. Additionally, RNA and pro-
tein extracts were prepared from the remaining cells. Flow
cytometric analysis confirmed that the thymocytes indeed
progressed from DN3 to first DN4 and then the DP stage
(Fig. 2 A).
Then, we analyzed the protein extracts for E-box DNA
binding activity by EMSA using a canonical oligonucle-
otide probe. E-box binding activity decreased 2.5–5-fold
within 12 h after anti-CD3
 
 
 
 injection (Fig. 2 B and data
not shown). These data suggest that E-box–binding activity
is regulated during the developmental transition induced by
 
 
 
 selection. We characterized the effect of 
 
 
 
-selection on
the binding of individual E-proteins by determining the
sensitivity of EMSA complexes from anti-CD3
 
 
 
–treated
and untreated RAG-deficient thymocyte extracts to inter-
ference by antibodies against specific E proteins. The
E-box complexes in thymocyte extracts from RAG-defi-
cient mice that were either untreated or injected with anti-
CD3
 
 
 
 24 h before preparation were primarily comprised of
E47 and HEB (Fig. 2 B), which are also the principal com-
ponents of E-box–binding complexes in wild-type thy-
mocyte extracts (7). Although the overall level of E-box
binding was decreased, the relative fractions of E-box com-
plexes containing E47, HEB, or both proteins did not
change significantly upon anti-CD3
 
 
 
 administration (Fig. 2
B). These data indicate that the developmental transition
induced by 
 
 
 
 selection is associated with a general decrease
in E-box DNA binding activity.
To determine the mechanism underlying the change in
E-box–binding activity, we examined the levels of E47 and
HEB proteins by immunoblotting. However, we found
that the modulation of E-box binding could not be ex-
plained by changes in the overall levels of E47 (Fig. 3 A) or
HEB (data not shown). We also determined the levels of
E47 by flow cytometry in RAG-deficient DN4 and DP
cells harvested 5 d after anti-CD3
 
 
 
 injection. Although the
levels of E47 are lowered slightly after progression to the
DP stage, this decrease comes well after the reduction in
E-box binding (Fig. 3 B). These data are also consistent
with the levels of E47 expression in wild-type thymocytes
as detected by flow cytometry (Fig. 1).
Previous studies indicated that Id3 levels are activated
upon TCR-mediated signaling in DP thymocytes, modu-
lating the DNA binding activity of E47/HEB heterodimers
(9). To examine whether RAG-deficient thymocytes
treated with anti-CD3
 
 
 
 also activated Id RNA levels, we
analyzed RNA derived from RAG-deficient thymocytes
by Northern blot analysis. While Id2 RNA levels changed
little throughout the time course we examined, Id3 RNA
levels were elevated dramatically within 3 h after anti-
CD3
 
 
 
 stimulation (Fig. 3, C and D). These results suggest
that the modulation of E box binding activity that occurs
after CD3 cross-linking on DN thymocytes in vivo is
caused, at least in part, by an induction of Id3 expression.
To assess the regulation of Id3 during normal thymocyte
development, we have examined the levels of Id3 RNA in
purified thymocyte populations from wild-type mice de-
fined on the basis of CD4 and CD8 expression. Id3 expres-
sion was found to be relatively high in DP thymocytes as
compared with the DN fraction, which is primarily com-
prised of thymocytes that have not yet undergone 
 
 
 
 selec-
tion (Fig. 3 E). Taken together, these data suggest that Id3
RNA is induced in thymocytes after the expression of the
pre-TCR complex.
The induction of Id3 through TCR cross-linking in DP
thymocytes is blocked by the MEK inhibitor PD98059, in-
dicating the involvement of the Ras-Raf-Erk signaling
pathway in this process (9, 29). We examined the role of
Ras–Erk signaling in Id3 induction by anti-CD3  in RAG-
deficient thymocytes by treating cultured RAG-1 /  neo-
natal thymi with anti-CD3  in the presence or absence of737 Engel et al.
PD98059. Treatment with anti-CD3  for 2 h was found to
induce Id3 transcription in RAG-1 /  fetal thymi, and this
induction was partially blocked by the presence of
PD98059 (Fig. 3 F). These data demonstrate the similarity
in the mechanisms of induction of Id3 upon CD3 cross-
linking in DP and DN thymocytes.
E2A Protein Deficiency Promotes Developmental Progression
in the Absence of pre-TCR-mediated Signaling. The obser-
vation that E47 DNA binding was inhibited upon cross-
linking of the CD3 complex in DN thymocytes raised
the possibility that E2A proteins play a role in blocking
the DN to DP transition in the absence of   selection.
Therefore, we generated mice deficient for both E47 and
RAG-1 and analyzed thymocytes from these mice for the
expression of CD4 and CD8 by flow cytometry. As dem-
onstrated previously, E47-deficient mice showed signifi-
cant decreases in the proportion of DP thymocytes com-
pared with the wild-type control littermates (Fig. 4 A,
reference 8). DP thymocytes were absent from RAG-1 / 
E47 /  mice, due to the block in TCR gene rearrange-
ment (Fig. 4 A, reference 1). However, the overwhelm-
ing majority of the thymocytes from the doubly deficient
mice expressed high levels of both CD4 and CD8 (Fig. 4
A). The DP thymocytes isolated from the RAG-1 / 
E47 /  mice expressed high levels of CD95 and low lev-
els of BCL-2, similar to that of wild-type DP thymocytes
(Fig. 4, E and F, and references 30 and 31). DP thy-
mocytes from mice deficient in both RAG-1 and E47
were also similar in size and cell-cycle status to that of
wild-type DP thymocytes (data not shown). Strikingly,
we also observed significant numbers of DP thymocytes
in 6 out of 11 mice analyzed with a RAG1 /  E47 / 
genotype (Fig. 4 C and data not shown). Thus a wild-
type gene dosage of E47 is required to ensure that all
RAG-deficient thymocytes arrest at the   selection
checkpoint.
Figure 2. Regulation of E-box–binding ac-
tivity during thymocyte   selection. RAG-1 / 
thymocytes were harvested at indicated times
after intraperitoneal anti-CD3  injection. (A)
Flow cytometric analysis of RAG-1 /  thy-
mocytes at various time points after injection of
anti-CD3 . The number of cells per thymus for
each time point is indicated above each column
of dot plots. Top row of dot plots shows CD4
versus CD8 expression profile of live-gated cells.
Bottom row shows CD44 versus CD25 profile
of live-gated DN cells. (B) EMSA of thymic
extracts binding to a  E5 oligonucleotide
probe. (Left) Thymocyte whole cell extracts (15
 g) prepared from unstimulated RAG-2 / 
mice (lanes 1–4) and RAG-2 /  mice injected
with anti-CD3  24 h before extract preparation
(lanes 5–8), were preincubated with 0.5  g of
irrelevant mouse IgG1 antibody (lanes 1 and 5),
anti-E47 (lanes 2 and 6), anti-E12 (lanes 3 and
7), or anti-HEB (lanes 4 and 8), before per-
forming EMSA using a  E5 probe. Arrows in-
dicate specific complexes. (Right) The same
extracts used in the left panel were tested for
binding to an Oct probe at 10  g per lane.738 E2A Proteins and Early T Cell Development
Upon   selection thymocytes undergo 6–7 rounds of
mitosis that result in an  100-fold expansion as the cells
differentiate to the DP stage (32). Thus even a weak dis-
ruption of the   selection checkpoint can result in a thy-
mus that consists primarily of DP cells. To assess directly
the effect of E2A deficiency on the   selection check-
point, we analyzed the DN thymocytes in RAG-1 / 
E47 /  mice. We found that the accumulation of cells in
the DN3 subset that is normally observed in RAG-1 null
mice was not seen in RAG-1 /  E47 /  thymocytes (Fig.
4 B). These data show that a deficiency in E2A protein re-
sults in complete abrogation of the developmental block
normally exhibited by thymocytes incapable of antigen re-
ceptor rearrangement.
E2A Protein Deficiency Allows Thymocyte Expansion in the
Absence of pre-TCR-mediated Signaling. Thymuses from
E47-deficient mice are hypocellular as compared with
wild-type littermate controls, due to a partial block at the
DN1 stage that precedes TCR gene rearrangement (7).
Thus, if a deficiency in E47 had no effect on the block in  
selection–driven proliferation observed in a RAG-1-null
background, then RAG-1 /  E47 /  mice would have
fewer thymocytes than littermates deficient for RAG-1 but
not E47. However, mice that were null for both RAG-1
and E47 consistently exhibited increases in total thymocyte
numbers relative to RAG-1 /  E47 /  or  /  littermates
(Fig. 4 D). Although the degree of this increase in cellular-
ity was variable, it should be noted that the numbers of
thymocytes recovered from RAG-1 E47 doubly null mice
were often well within the range recovered from mice de-
ficient only for E47 (reference 8 and data not shown).
RAG-1 /  E47 /  thymuses, either with or without DP
cells, in most cases did not exhibit significant increases in
cellularity relative to that observed in RAG-1–null E47 / 
mice (data not shown). These data indicate that E2A pro-
teins are required for inhibiting both the differentiation and
proliferation of RAG-1 null thymocytes.
E2A Protein Deficiency Promotes the Developmental Progres-
sion of Thymocytes in scid Mice through a Mechanism Distinct
from p53. We also examined the effect of E2A deficiency
on the T cell developmental block in mice homozygous for
the scid mutation. The scid defect is caused by a mutation
that results in a severe reduction in DNA-dependent pro-
tein kinase (DNA–PK) activity (33). Because DNA-PK ac-
tivity is required for the efficient joining of broken DNA
ends generated by RAG-mediated cleavage, scid thymocytes
are unable to complete TCR gene rearrangement, and so
are arrested at   selection (23). However, the overwhelm-
ing majority of the thymocytes from the scid E47 /  mice,
like those from E47 and RAG-1–deficient mice, expressed
high levels of both CD4 and CD8 (Fig. 5 A). Analysis of
the DN thymocytes confirmed that the developmental
block at the DN3 stage in scid mice is relieved by a defi-
ciency in E47 (Fig. 5 B). Cellular expansion was also signif-
icantly rescued in scid mice that lacked E47 expression, as
compared with scid E47 wild-type littermates (Fig. 5 C).
Figure 3. Regulation of E47, Id2, and Id3 during thymocyte   selection. (A) Immunoblot analysis of E47 protein levels in thymic whole cell extracts
from RAG-1 /  mice prepared 0 or 12 h after anti-CD3  injection. Protein loading was judged to be approximately equivalent by amido black staining
(data not shown). (B) E47 levels as measured by flow cytometry in DP (solid thin line) and DN4 (solid thick line) thymocyte populations from RAG-
deficient mice analyzed 5 d after anti-CD3  injection, as compared with the staining of control RAG-deficient (stippled line) and E47 /  (dotted line)
thymocytes. (C) Northern blot analysis of Id2 and Id3 transcripts in RNA from RAG-1 /  thymocytes prepared 0 or 12 h after anti-CD3  injection. The
bar graph depicts the relative signal strength of Id2 (white bar) and Id3 (black bar) as quantitated by phosphorimage analysis, normalizing to the signal after
probing for GAPDH. (D) Northern blot analysis of Id3 expression in RAG-1 /  thymocytes harvested 0, 3, 6, 9, and 12 h after anti-CD3  injection. The
bottom panel depicts the staining of the transferred RNA samples with ethidium bromide. (E) Northern blot analysis of RNA from thymocyte popula-
tions from wild-type mice subdivided on the basis of CD4 and CD8 expression. (Top) Blot probed for Id3. (Bottom) The same blot probed for GAPDH.
(F) Northern blot analysis of RAG-1 /  thymus organ cultures treated with or without anti-CD3  for 2 h in the presence and absence of 30  M
PD98059. Bar graph depicts the normalized fold increase of Id3 RNA induced by treatment with anti-CD3  in the presence and absence of PD98059.739 Engel et al.
Thymuses from mice deficient for p53 in a scid back-
ground also contain some DP thymocytes (34–36). A large
fraction of the DP thymocytes isolated from scid p53 / 
mice expressed the TCR   chain (35). These observations
led to the conclusion that a deficiency in p53 allows some
scid thymocytes to repair RAG-mediated DNA breaks
through alternative repair pathways and undergo   selec-
tion-driven expansion and differentiation. To determine
whether similar phenomena occur in scid E47 /  mice,
cells were made permeable and analyzed for the presence of
TCR   chain by flow cytometry. We found that DP thy-
mocytes from mice homozygous for the E47 and scid muta-
tions did not show detectable levels of   chain expression
(Fig. 5 D). Thus, a deficit in E2A proteins allows thy-
mocyte expansion and differentiation in mice with defects
in TCR rearrangement through a pathway distinct from
those regulated by p53.
E2A Protein Deficiency Can Allow for Differentiation of
RAG-1 or scid Mutant Thymocytes to the CD8 SP Stage.
We have also observed in some mice deficient for E47 and
either RAG-1 or DNA-PK a thymocyte population that
expresses high levels of CD8 but low levels of CD4 (Figs. 4
Figure 4. E47 deficiency promotes the aberrant development of RAG-1 null thy-
mocytes. (A) Dot plots depicting surface CD4 and CD8 expression, as determined by
flow cytometry, on thymocytes from 1-mo-old mice with RAG-1 /  E47 / ,
RAG-1 /  E47 / , RAG-1 /  E47 / , and RAG-1 /  E4 /  genotypes. The
RAG-1 /  E47 /  mouse used for this experiment was from a separate litter and an-
alyzed separately from the other three mice. Numbers indicate the percentage of via-
ble cells found in each quadrant. (B) Flow cytometric analysis of surface CD44 and
CD25 expression on CD3 CD4 CD8  thymocytes from a 3.5-wk-old RAG-1 / 
E47 /  mouse and three littermates. Numbers indicate the percentage of viable DN
cells found in each quadrant. (C) Dot plots depicting surface CD4 and CD8 expres-
sion on thymocytes from 1-mo-old RAG-1 /  littermates that were either wild-type
or heterozygous for E47, illustrating the appearance of DP thymocytes in some
RAG-1 /  E47 /  mice. The percentage of DP thymocytes observed in RAG-1 /  E47 /  mice with significant numbers of DP thymocytes has ranged
from  2–85% (data not shown). (D) Scatter plot indicating the number of thymocytes obtained from six RAG-1 /  E47 /  mice as compared with
RAG-1 /  E47 wt or  /  littermates. Thymus cellularity in E47 /  mice typically ranges from 1.5–5   107 cells (data not shown). (E) Histograms of sur-
face CD95 (Fas antigen) expression in selected thymocyte populations as measured by flow cytometry. (Thick line) DP thymocytes from a 4-wk-old
E47 /  RAG-1 /  mouse. (Thin line) DN thymocytes from a RAG-1 /  E47 /  littermate. (Dotted line) DP thymocytes from a RAG-1 /  E47 /  lit-
termate. (F) Histograms of BCL-2 expression levels in selected thymocyte populations as measured by flow cytometry. (Thick line) DP thymocytes from
a 1-mo-old E47 /  RAG-1 /  mouse. (Thin line) DN thymocytes from a RAG-1 /  E47 wild-type littermate. (Dotted line) DP thymocytes from a
RAG-1 /  E47 /  littermate. All data presented are representative of analyses of at least three individual RAG-1 /  E47 /  mice and littermate controls.740 E2A Proteins and Early T Cell Development
Figure 5. Analyses of thymocytes from mice homozygous for the scid and E47-null mutations. (A) Surface CD4 and CD8 expression, as determined by
flow cytometry, on thymocytes from a 5-wk-old scid/scid E47 /  mouse and three littermates. Numbers indicate the percentage of viable cells found in
each quadrant. (B) Flow cytometric analysis of surface CD44 and CD25 expression on DN thymocytes from a 5-wk-old scid/scid E47 /  mouse and
three littermates. Numbers indicate the percentage of viable, DN cells found in each quadrant. (C) Scatter plot indicating the number of thymocytes ob-
tained from three scid/scid E47 /  mice as compared with scid/scid E47 wild-type littermates. (D) Expression of TCR   chain in selected populations of
fixed and permeabilized thymocytes as determined by flow cytometry. Thick line: DP thymocytes from a 5-wk-old scid/scid E47 /  mouse. (Dashed line)
DP thymocytes from a /  E47 /  littermate. (Thin line) DN thymocytes from a 6-wk-old RAG-1 /  E47 wild-type mouse. (E) CD4 and HSA expres-
sion on the CD8high thymocytes from a 5-wk-old scid/scid E47 /  mouse and littermates. Plot on left depicts CD4 and CD8 expression in scid/scid E47 / 
thymocytes, with gate drawn to define CD8high cells. The other plots depict the expression of CD4 and HSA in the CD8high population of scid/scid E47 / 
and littermate control thymocytes. Note that the CD8high CD4  (CD8 SP) scid/scid E47 /  thymocytes are also HSAlow. Similar data were obtained from
RAG-1 /  E47 /  mice; however in some RAG-1 /  E47 /  and scid/scid E47 /  mice we did not detect CD8 SP HSAlow thymocytes (data not
shown). All other data presented in Fig. 5 are representative of analyses of three individual scid/scid E47 /  mice and littermate controls.741 Engel et al.
A and 5 A). This phenotype could be representative of ei-
ther an immature SP population that is in transition from
the DN4 to the DP stage, or cells that have differentiated
from the DP to the mature CD8 SP stage. To determine if
these cells represented mature CD8 SP cells, we analyzed
thymocytes from E47-null mice deficient for either RAG
or DNA–PK activity for the expression of the heat stable
antigen (HSA). HSA is expressed at high levels in immature
SP and DP thymocytes but is downregulated upon transi-
tion to the SP stage (26). Interestingly, the CD8hi CD4lo
cells present in E47 /  RAG-1 /  and E47 /  scid mice
were often predominately HSAlo (Fig. 5 E). However, we
note that CD8hi CD4lo HSAlo thymocytes were absent
from some of the E47 /  RAG-1 or scid mutant mice ex-
amined. We have not detected CD4 SP thymocytes with a
mature phenotype (Figs. 4 and 5 A, and data not shown).
These data suggest that thymocytes lacking the expression
of a TCR complex in the absence of E47 can progress to
the mature CD8 but not the CD4 SP stage. However, the
development of CD8 SP cells in an E47- and TCR-defi-
cient background is likely influenced by other genetic or
environmental factors.
E2A Protein Deficiency Promotes the Thymic Developmental
Progression of RAG-deficient Bone Marrow Cells Transferred
into an Irradiated E2A /  Host. The observation that E47
DNA binding activity in RAG-deficient thymoyctes was
inhibited by cross-linking of the CD3 complex strongly
suggested that the effects of E2A protein deficiency in
RAG-null mice are due to a deficit of E2A activity in the
developing thymocytes. However, it remained formally
possible that defects in E2A-deficient thymic stromal cells
contributed to the phenotype of RAG-1 /  E47 /  thy-
mocytes. Thus we reconstituted a lethally irradiated, RAG-
2 /  mouse with bone marrow from an E47 /  RAG-1 / 
mouse, and then analyzed the thymocytes 6 wk after trans-
fer. The thymocytes obtained from this chimeric mouse
showed a surface phenotype that was indistinguishable
from that of the E47 /  RAG-1 /  and E47 /  scid mice
we have analyzed (Figs. 4–6). Thus defects in radioresistant
thymic epithelial cells do not contribute to the aberrant de-
velopmental progression observed in thymocytes deficient
for both E2A and RAG activity.
Discussion
The data presented here demonstrate that E2A proteins
play important roles in at least two distinct stages of early T
cell development. Flow cytometric analysis reveals that
thymocytes start to express uniformly high levels of E47 at
the point at which their developmental potential begins to
be narrowed towards a T cell fate (Fig. 1). These data are
consistent with observations of the phenotype of E2A-defi-
cient thymocytes, which display a developmental arrest just
before the stage at which E47 is normally induced. How-
ever, while E47 expression remains high during subsequent
stages of DN thymocyte maturation, our data reveal that
E47 DNA binding activity is inhibited by signaling through
the pre-TCR complex (Figs. 1–3). Furthermore, we find
that E2A proteins are required to prevent the developmen-
tal progression of DN thymocytes in the absence of TCR- 
rearrangement, and hence pre-TCR expression (Figs. 4
and 5). The combination of the genetic and biochemical
evidence strongly imply that E2A proteins act to block thy-
mocyte maturation in the absence of pre-TCR expression,
and that pre-TCR signaling acts to promote development
in part by modulating E2A activity. As expected, we did
not observe any effect of rearrangement defects on the B
cell phenotype of E2A-deficient mice, as B cell develop-
ment in E47 /  mice is completely blocked before Ig rear-
rangement (data not shown, and reference 6). Taken to-
gether, the studies described here provide a mechanism
linking pre-TCR signaling and E2A to developmental pro-
gression and cellular expansion.
E2A Proteins Are Negatively Regulated during the Differentia-
tion of both DN and DP Thymocytes. Many of the signaling
molecules that are necessary for   selection have also been
shown to play roles in the transition of thymocytes from
the DP to the SP stage. This is not surprising, given that
both the pre-TCR and the    TCR utilize the CD3 anti-
gen complex for the initiation of signal transduction upon
receptor binding (37). Recent reports have demonstrated
that E2A functions to attenuate positive selection, and that
E2A activity is inhibited by TCR cross-linking in DP thy-
mocytes (8). Taken together with the results reported here,
these data suggest that the signaling pathways activated by
both the TCR and pre-TCR negatively regulate E2A pro-
tein activity, and that modulation of E2A is critical to mul-
tiple stages of T cell development.
The bHLH inhibitor Id3 has been shown to be upregu-
lated by TCR cross-linking in DP thymocytes through a
Figure 6. Surface staining of
thymocytes from a RAG-2 / 
mouse that was lethally irradiated
and reconstituted with E47 / 
RAG-1 /  bone marrow 6 wk
before analysis. A RAG-deficient
host was used because the donor
bone marrow was from a mixed
genetic background. (A) Surface
CD8 and CD4 expression. (B)
Surface CD44 and CD25 ex-
pression on DN thymocytes.
The DN3 cells were found to be
 3% positive when stained with
anti-E47, indicating that the vast
majority of the DN thymocytes
were donor derived (data not
shown). 4.2   106 cells were re-
covered from this thymus, which
is within the range obtained
from irradiated hosts reconsti-
tuted with E2A-deficient bone
marrow (data not shown).742 E2A Proteins and Early T Cell Development
pathway dependent upon the Erk–MAPK cascade (9). We
have also observed that Id3 RNA is dramatically upregu-
lated in RAG-1 /  thymocytes stimulated by anti-CD3 
(Fig. 3, C and D), and that this induction of Id3 is also
sensitive to inhibitors of the Ras-Erk–MAPK signaling
pathway (Fig. 3 E). Thus it is likely that similar signaling
pathways are involved in the inhibition of E47 activity
upon cross-linking antigen receptor complexes in DN and
DP thymocytes.
The presence of CD8 SP thymocytes with a mature phe-
notype in several E47 /  mice with blocks in TCR   chain
rearrangement provides additional evidence demonstrating
that E2A proteins are important negative regulators of the
positive selection of DP thymocytes (Fig. 5 E). The consis-
tent absence of mature CD4 SP thymocytes from E47 / 
RAG-1 /  or E47 /  scid mice defines a distinction be-
tween the signaling events required for the generation of
CD8 and CD4 SP cells. Thus while a decrease in E2A ac-
tivity may be sufficient for the transition of thymocytes
from the DP to the CD8 SP stage, additional events appear
to be necessary for the positive selection of CD4 SP thy-
mocytes. Our observations are also consistent with data
demonstrating that the absence of E47 results in a greater
enhancement of selection to the CD8 lineage than to CD4
(8). Furthermore, it has been shown that E2A deficiency
allows the development of some CD8 SP T cells in a  2
microglobulin–null background, in which positive selec-
tion to the CD8 lineage is normally blocked (8).
In addition, our data indicate that the levels of E2A pro-
teins are also regulated during thymocyte development.
E47 levels become relatively high at the DN2 stage, then
are lowered in DP cells and barely detectable in SP thy-
mocytes. E2A RNA levels are about the same in the DN,
DP, and SP populations, suggesting that E47 expression in
thymocytes is likely to be posttranscriptionally regulated
(unpublished data). The specific mechanisms by which E47
protein levels are regulated remain to be elucidated. Thus
our data indicate that E2A activity is regulated during thy-
mocyte development through mechanisms that affect the
levels of E2A protein and Id3.
Figure 7. (A) Model outlining the role and regulation of E2A during T cell development. (B)
Model depicting mechanisms by which TCR signaling inhibits E2A activity and defined func-
tions of E2A that may act to promote normal thymocyte development.743 Engel et al.
Deficiencies in E47 and p53 Allow Thymocyte Progression
through Distinct Mechanisms. The p53 tumor suppressor is
another transcription factor that has a role in preventing
maturation in the absence of pre-TCR expression (34–36,
38, 39). However, although both E2A and p53 have been
shown to be required for the suppression of the DN to DP
transition in scid thymocytes, there are sharp differences in
the way they mediate this block. p53 is known to be acti-
vated by double strand DNA breaks, and has been shown
to be expressed at elevated levels in scid thymocytes, which
contain RAG-mediated strand breaks that cannot be effi-
ciently repaired (35). The DP thymocytes that develop in
mice deficient for both p53 and DNA–PK have been re-
ported to express the TCR   chain (35). These data sup-
port a model in which a deficiency in p53 allows some scid
thymocytes to complete in frame VDJ  rearrangement and
thus pass the   selection checkpoint. In contrast, DP thy-
mocytes that are homozygous for the E47 and scid muta-
tions do not express the   chain (Fig. 5 D). We should add
that E2A deficiency by itself does not significantly affect the
expression levels of either surface or intracellular   chain
(data not shown). Thus the rescue of development in scid
mutant mice to the DP stage by E47 deficiency is not likely
to occur by a delay in apoptosis that allows   rearrange-
ment, as is the case in a p53-deficient background.
Role of E2A Proteins during Thymocyte Development. The
data presented above, together with other recent studies of
the roles of E-proteins at several stages of T cell develop-
ment, suggest a model for how modulation of E2A protein
activity acts to promote thymocyte differentiation (Fig. 7
A). The observation that the developmental arrest in E2A-
deficient mice occurs just before the appearance of the ear-
liest thymocyte subset to express uniformly high levels of
E47 strongly implies that E2A expression in thymocytes is
important for the initial stages of T cell differentiation (7).
There have been a number of studies implicating E2A pro-
teins in the regulation of genes required for early T cell de-
velopment (Fig. 7 B). Id3 overexpression has been shown
to inhibit pre-T  transcription in committed T cell pro-
genitors (22). The proteins encoded by E2A and HEB pos-
itively regulate the RAG-1 and RAG-2 genes (21). In
addition, we have recently demonstrated that, using a
RAG–GFP transgene, proper RAG expression in DN thy-
mocytes requires the presence of the E2A proteins (unpub-
lished data). Furthermore, bHLH proteins have also been
shown to be required to promote TCR V(D)J  rearrange-
ment in thymocytes (20). Thus E2A proteins have an im-
portant role in initiating the T cell developmental program.
E47 DNA binding activity is then lowered at subsequent
stages of thymocyte development by signaling initiated
through the CD3 complex. The downregulation of E2A
activity is dependent upon signaling through the pre-TCR
complex in DN thymocytes and appears necessary for the  
selection developmental transition (Figs. 2, 4, and 5). It is
conceivable that this modulation of E2A DNA binding af-
fects RAG gene expression and inhibits accessibility to the
TCR-  locus. The roles of E2A proteins in TCR rear-
rangement and RAG gene expression also imply that the
reduction of E-box–binding activity upon   selection may
contribute to allelic exclusion as well.
Our data also indicate that a deficit of E2A promotes
cellular expansion, which suggests that E2A proteins func-
tion to block the proliferation of DN thymocytes in the
absence of   selection. E2A activity has previously been
shown to induce cell-cycle arrest in fibroblasts and lym-
phoid cells (10, 11). We have also observed that E2A pro-
teins can induce G1 arrest in some lymphoma lines (un-
published data). These findings are consistent with our
observation that E2A proteins are required to prevent the
proliferative expansion of thymocytes in the absence of
pre-TCR expression and suggest that the downregulation
of E2A activity by pre-TCR signaling could help promote
cell-cycle progression in DN3 thymocytes. It is also possi-
ble that E2A proteins may contribute to the induction of
apoptosis in DN thymocytes that have failed   selection,
as E2A protein activity can also induce apoptosis in some
cell lines (11, 12).
E2A Proteins and Lymphomagenesis. Genetic alterations
that allow for development to the DP stage in the absence
of   selection are frequently oncogenic. Thus deficiencies
in E47, p53, or Ikaros, as well as overexpression of Lck or
Pim-1 result in both the generation of DP cells in RAG-
null or scid mice and in a high susceptibility to thymic lym-
phoma (7, 36, 40–46). Since the   selection developmental
transition is marked by rapid proliferation, it is possible that
factors that block aberrant progression of DN thymocytes
also inhibit the growth of transformed T lymphocytes. It
will thus be interesting to explore the relationship of the
roles of E2A proteins in normal thymocyte development
and lymphoma suppression.
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